Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
NCT04502069
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
To be replaced with a randomized placebo-controlled study.
Conditions
COVID-19
Lung Infection
Interventions
DRUG:
Opaganib
Sponsor
RedHill Biopharma Limited